Our Programs

Using genomics to identify therapeutic options for patients with advanced solid or blood cancer of any type and to manage cancer risk.

Molecular Screening & Therapeutics (MoST) study

We are using the power of genomic technology to characterise molecular changes in a patient’s cancer that may help to identify a targeted therapy.

Read More

Genetic Cancer Risk in the Young (RisC) study

Understanding the genetic variants that contribute to inherited cancer.

Read More

Surveillance study in Multi-Organ Cancer prone syndromes (SMOC+)

Investigating and evaluating the surveillance practices used for people at high risk of multi-organ cancer.

Read More

Australian Rare Cancer (ARC) Portal

Referring patients to the Australian Rare Cancer portal gives streamlined access to expert opinion and advice on management and treatment options.

Read more